Chief Operating Officer - Crmi Group
CurrentA) Develop and Manage Business Result• Tissue engineering (TE) & Regular medical devices BU involving Oral, Ophthalmic & General surgery• Cell therapy and genetic engineering BU, including CMO and therapeutic product development• Bio-cosmetics & healthcare clinic BU, including skincare product; dental, optical and aesthetic clinicB) Corporate strategy and implementationC) M&A opportunity, negotiation and operationD) Manufacturing & Quality Assurance… Show more A) Develop and Manage Business Result• Tissue engineering (TE) & Regular medical devices BU involving Oral, Ophthalmic & General surgery• Cell therapy and genetic engineering BU, including CMO and therapeutic product development• Bio-cosmetics & healthcare clinic BU, including skincare product; dental, optical and aesthetic clinicB) Corporate strategy and implementationC) M&A opportunity, negotiation and operationD) Manufacturing & Quality Assurance OperationE) Corporate operating system establishmentF) Corporate product R&D• Boosted revenue to HKD 75M from HKD 3M in two years• Expedited and launched 3 self-developed bio-engineered medical devices (acellular cornea, dental membrane & fistula stroma), a series of bio-cosmetics and another series of Swiss active-cosmetic in China market within two years.• Managed & Ensured 8 manufacturing factories' operation, quality and distribution. Including found a bGMP cleanroom factory in Hong Kong; upgraded 2 cell therapy factories in China to cGMP cleanroom standard to facilitate human stem cell and immune cell fabrication CMO business• Forged M&A deals of USD 68M, including an Israeli dental implant and a China surgical stapler factory• Formulated 5-years strategic plan, 3-years operation plan, annual operation budget with EBIT commitments endorsed by BOD• Incorporated CRMI Technology Center in Oxford University and consolidated originally disperse product development activities into a unified “Technology Translation platform”• Partnered with Ethiopia Minister of Health for product license approval, which is a base for all products being approved for clinical use in the whole Africa continent. Contracted with government of Shanghai, Nanchang & Hainan on high-tech investment Show less